Cardiovascular Diagnostic Antibody Development Services

Diagnostic antibodies play an irreplaceable and critical role in in vitro diagnostic studies related to cardiovascular disease. Ace Therapeutics is committed to providing researchers with customized development services for diagnostic antibodies in order to promote new advances in cardiovascular disease research.

Overview of Diagnostic Antibodies

Immunodiagnostic reagents are the main types of diagnostic reagents currently used in the field of in vitro diagnosis of cardiovascular diseases. The principle of immunodiagnostics is to use the specific binding reaction between antigen and antibody to carry out qualitative or quantitative diagnostics of disease, and diagnostic antibody is one of the indispensable raw materials, which can be used as a labeling antibody, capture antibody, or detection antibody, which plays an indispensable role in all aspects of immunodiagnostics.

Fig. 1 Damage-associated molecular patterns (DAMP) in coxsackievirus B3 infection of cardiomyocytes leading to cell damage and death. (Tschöpe C, et al., 2021)

Diagnostic antibodies are a key point of research and development in the field of in vitro diagnostics for cardiovascular diseases. Ace Therapeutics is committed to providing researchers with a large number of accessible antibody products or diagnostic antibody development services.

Antibodies for Cardiovascular Research

For in vitro diagnostic studies of cardiovascular diseases, we have a wide range of antibody products to help you carry out related experimental work.

Diagnostic Antibody Development Services for Cardiovascular Diseases

Based on the individual needs of researchers for diagnostic antibodies, we can provide customized antibody preparation services.

• Diagnostic Antibody Production
  We can custom develop the following types of cardiovascular disease diagnostic antibodies for our customers according to their individual experimental needs.
  • Polyclonal Antibodies
  • Monoclonal Antibodies

  • Recombinant Antibodies (Genetically Engineered Antibodies)
  Common cardiovascular disease diagnostic antibody targets are shown below:
  • Creatine Kinase (CK)
  • Creatine Kinase MB (CK-MB)
  • Cardiac Troponin T (cTnT)
  • Cardiac Troponin I (cTnI)
  • C-Reactive Protein (CPR)

  • Brian Natriuretic Peptide (BNP)
  • N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP)
  • Fatty Acid Binding Protein (FABP)
  • Glycogen Phosphorylase BB (GPBB)
  • Ischemic Modified Albumin (IMA)
• Validation of Diagnostic Antibodies
  Antibodies used in diagnostic tests need to have good specificity and stability to ensure reliable results in qualitative and quantitative tests.
  • Antibody Activity Validation
  • Antibody Potency Validation
  • Antibody Affinity Validation

  • Antibody Specificity Validation
  • Antibody Purity Validation
  • Antibody Stability Validation

Ace Therapeutics is a leading developer of in vitro diagnostic reagents for cardiovascular disease. We are dedicated to providing customers with comprehensive diagnostic antibody development solutions. If you are interested in our services, please don't hesitate to contact us.

1. Tschöpe, C.; et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021, 18(3): 169-193.